Unsupervised PrEP in routine practice: a new challenge?. (June 2019)

• Record Type: Journal Article
• Authors: Laroche, Hélène; Lions, Caroline; Zaegel-Faucher, Olivia; Tamalet, Catherine; Poizot-Martin, Isabelle
• Is Part Of: International journal of STD & AIDS. Volume 30:Number 7(2019)
• Page Start: 715
• Page End: 717
• Publication Date: 2019-06
• Subjects: Prevention -- human immunodeficiency virus -- sexual behaviour -- diagnosis -- treatment; Sexually transmitted diseases -- Periodicals; AIDS (Disease) -- Periodicals; 616.951
• DOI: 10.1177/0956462419828872
• Languages: English
• ISSNs: 0956-4624

Abstract

Pre-exposure prophylaxis (PrEP) for the prevention of HIV infection with 300 mg daily tenofovir co-formulated with 200 mg emtricitabine is recommended as one prevention option for people who are at substantial risk of acquiring an HIV infection. We report the case of a 28-year-old man who has sex with men and who was referred to our unit for a primary HIV infection with positive p18, p24 and gp160 bands on Western blot analysis but with a low HIV plasma viral load. Although HIV misdiagnosis should always be considered in cases of atypical seroconversion pattern with a low viral burden, unsupervised PrEP should be systematically investigated.